Shiou-Ting Chen

Title: **Inventor Profile: Shiou-Ting Chen**

Introduction

Shiou-Ting Chen is an accomplished inventor based in New Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for cancer treatment. His innovative work has culminated in the acquisition of a patent that highlights his expertise and impact in this critical area of research.

Latest Patents

Chen holds a patent for "Human anti-CD47 antibodies and uses thereof." This groundbreaking invention focuses on antibodies that bind to CD47 with high affinity and specificity. The patent outlines the potential applications of these antibodies in the treatment of various cancers, showcasing Chen's commitment to advancing medical science and improving patient outcomes.

Career Highlights

Currently, Shiou-Ting Chen is associated with Trican Biotechnology Co., Ltd., a company dedicated to research and development in the biopharmaceutical sector. His role there allows him to leverage his skills in biotechnology and patent innovation, contributing to the creation of new therapeutic solutions.

Collaborations

Throughout his career, Chen has collaborated with distinguished colleagues, including Huang-Tsu Chen and Jiun-Shyang Leou. These partnerships have facilitated knowledge exchange and enhanced research capabilities, enabling the pursuit of novel approaches to cancer treatment.

Conclusion

In summary, Shiou-Ting Chen is a prominent inventor whose work in the realm of anti-CD47 antibodies underscores his dedication to fighting cancer. His patent and collaborative efforts within Trican Biotechnology Co., Ltd. reflect his significant contributions to the field of biotechnology and the ongoing quest for innovation in medical treatments. Chen's achievements inspire future generations of inventors and researchers aiming to make a difference in healthcare.